[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352140-105":59,"doc-detail-352140-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immune-checkpoints-and-immunoregulation-in-metabolic-diseases-and-cancers-pathological-mechanisms-and-therapeutic-potential","Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential","","Global metabolic diseases, especially obesity, diabetes mellitus, and thyroid disorders, have surged in recent decades, creating a major public-health burden. Although conventional drug therapies remain central, they are limited by adverse effects and emerging drug resistance, motivating alternative strategies. Immune checkpoint pathways—initially pivotal in cancer immunotherapy—are increasingly recognized as regulators of metabolic homeostasis. The PD-1/PD-L1 axis coordinates inflammatory programs and energy metabolism, and checkpoint modulation shows therapeutic promise, particularly across obesity, diabetes, and thyroid disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immune-checkpoints-and-immunoregulation-in-metabolic-diseases-and-cancers-pathological-mechanisms-and-therapeutic-potential/352140/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immune-checkpoints-and-immunoregulation-in-metabolic-diseases-and-cancers-pathological-mechanisms-and-therapeutic-potential/352140.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are immune checkpoints and why are they important for immune homeostasis?","Question",{"text":112,"@type":113},"Immune checkpoints are inhibitory immunoregulatory molecules that function as “brakes” to prevent excessive immune activation and maintain self-tolerance. They primarily act on immune cell surfaces, helping preserve immune balance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does immune checkpoint blockade strengthen antitumor immunity?",{"text":117,"@type":113},"Therapeutic blockade enhances antitumor immunity by increasing tumor-infiltrating lymphocytes, boosting cytotoxic T lymphocyte and NK cell–mediated killing, reprogramming tumor-associated macrophages and MDSCs toward immunostimulatory phenotypes, and suppressing regulatory T cell recruitment and function.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are immune checkpoints relevant to metabolic diseases such as obesity and diabetes?",{"text":121,"@type":113},"Immune checkpoint pathways are described as pivotal regulators of metabolic homeostasis. Evidence highlighted in the text shows that PD-1/PD-L1 signaling can influence inflammatory responses and energy metabolism, including shifting adipose tissue macrophage polarization in obesity to reduce chronic low-grade inflammation and metabolic dysfunction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352140,1790871263,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nREVIEW ARTICLE  \nOPEN  \nImmune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential  \nMinmin Xiang1, Shuang Liu 2 ✉, Desheng Xiao 1,3 ✉ and Yongguang Tao 1,4 ✉  \n\n|  |  |  |\n| --- | --- | --- |\n|  | The global prevalence of metabolic diseases, notably obesity, diabetes mellitus, and thyroid disorders, has risen dramatically in recent decades, posing a signiﬁcant threat to public health. While conventional pharmacological interventions remain the cornerstone of management, they face considerable limitations, including adverse effects and the development of drug resistance, underscoring the urgent need for alternative therapeutic strategies. Intriguingly, immune checkpoint molecules, originally recognized for their transformative role in cancer immunotherapy, are now gaining attention as pivotal regulators of metabolic homeostasis. Growing research demonstrates that immune checkpoint pathways, particularly the PD-1/PD-L1 axis, play dual roles in immune regulation and metabolic modulation by orchestrating inﬂammatory responses and energy metabolism. For instance, in obesity, PD-1/PD-L1 signaling promotes the polarization of adipose tissue macrophages from a proinﬂammatory M1 phenotype toward an anti-inﬂammatory M2 state, thereby mitigating chronic low-grade inﬂammation and associated metabolic dysfunction. These ﬁndings highlight the potential of immune checkpoint modulation as a novel therapeutic strategy for metabolic disorders. However, despite these advances, the role of immune checkpoints in metabolic diseases remains underexplored, with limited comprehensive reviews on the subject. This review comprehensively elucidates the pathophysiological mechanisms and translational potential of immune checkpoint regulation in obesity, diabetes, and thyroid disease while proposing novel directions |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | for clinical intervention. |  |\n|  |  |  |\n|  |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:360 ; [https://doi.org/10.1038/s41392-026-02810-5](https://doi.org/10.1038/s41392-026-02810-5) |  |\n|  |  |  |\n\nINTRODUCTION  \nImmune checkpoints are a class of immunoregulatory molecules that serve as critical inhibitory mechanisms in the immune system, functioning as biological ‘brakes’ to maintain immune homeostasis.1 Primarily expressed on immune cell surfaces (including T cells, B cells, and other lymphocytes), these molecules act as gatekeepers to prevent excessive immune activation and preserve self-tolerance.2 However, tumors strategically exploit these pathways to evade immune surveillance.3 Therapeutic blockade of immune checkpoints signiﬁcantly enhances antitumor immunity through multiple mechanisms: (1) promoting the accumulation of tumor-inﬁltrating lymphocytes (TILs) within the tumor microenvironment,(2) augmenting tumor cell killing mediated by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells,(3) reprogramming tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) from immunosuppressive to immunostimulatory phenotypes, and (4) suppressing the recruitment and function of regulatory T cells (Tregs) .4 Therapeutic strategies targeting immune checkpoints, therefore, have emerged as a transformative approach in oncology. Immune checkpoint blockade (ICB) has revolutionized cancer treatment, demonstrating remarkable clinical efﬁcacy across multiple malignancies.5,6  \nThe discovery and characterization of novel immune checkpoint molecules represents an active area of investigation in modern immunotherapy research. Among the most clinically signiﬁcant immune checkpoints are the programmed death 1 (PD-1)/ programmed cel","cbCaieZndwAyU8k3","https://ap.wps.com/l/cbCaieZndwAyU8k3","pdf",4490930,26,"English","# Introduction\n## Immune checkpoint blockade in oncology\n## Expansion of checkpoint therapy to metabolic diseases\n# Overview of metabolic diseases and rationale for review\n## Obesity, diabetes, and thyroid disorders","[{\"question\":\"What are immune checkpoints and why are they important for immune homeostasis?\",\"answer\":\"Immune checkpoints are inhibitory immunoregulatory molecules that function as “brakes” to prevent excessive immune activation and maintain self-tolerance. They primarily act on immune cell surfaces, helping preserve immune balance.\"},{\"question\":\"How does immune checkpoint blockade strengthen antitumor immunity?\",\"answer\":\"Therapeutic blockade enhances antitumor immunity by increasing tumor-infiltrating lymphocytes, boosting cytotoxic T lymphocyte and NK cell–mediated killing, reprogramming tumor-associated macrophages and MDSCs toward immunostimulatory phenotypes, and suppressing regulatory T cell recruitment and function.\"},{\"question\":\"Why are immune checkpoints relevant to metabolic diseases such as obesity and diabetes?\",\"answer\":\"Immune checkpoint pathways are described as pivotal regulators of metabolic homeostasis. Evidence highlighted in the text shows that PD-1/PD-L1 signaling can influence inflammatory responses and energy metabolism, including shifting adipose tissue macrophage polarization in obesity to reduce chronic low-grade inflammation and metabolic dysfunction.\"}]","Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential | PDF",1790097871,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29e652c52e7a5824b308980780dcc46f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/444d6fac1b57c49d69b91b0a27e6a0cf.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da5b65d4048311f9445b6238e2ead53c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/452c7fd304a78967beb3d5c9f11d7131.webp",980,1301]